Altered metabolic gene expression in the brain of a triprolyl-human amylin transgenic mouse model of type 2 diabetes
Open Access
- 10 October 2019
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-14
Abstract
Type 2 diabetes mellitus is a major health concern worldwide; however, the molecular mechanism underlying its development is poorly understood. The hormone amylin is postulated to be involved, as human amylin forms amyloid in the pancreases of diabetic patients, and oligomers have been shown to be cytotoxic to β-cells. As rodent amylin is non-amyloidogenic, mice expressing human amylin have been developed to investigate this hypothesis. However, it is not possible to differentiate the effects of amylin overexpression from β-cell loss in these models. We have developed transgenic mice that overexpress [25, 28, 29 triprolyl]human amylin, a non-amyloidogenic variant of amylin, designated the Line 44 model. This model allows us to investigate the effects of chronic overexpression of non-cytotoxic amylin. We characterised this model and found it developed obesity, hyperglycaemia and hyperinsulinaemia. This phenotype was associated with alterations in the expression of genes involved in the amylin, insulin and leptin signalling pathways within the brain. This included genes such as c-Fos (a marker of amylin activation); Socs3 (a leptin inhibitor); and Cart, Pomc and Npy (neuropeptides that control appetite). We also examined Socs3 protein expression and phosphorylated Stat3 to determine if changes at the mRNA level would be reflected at the protein level.Keywords
Funding Information
- Ministry of Business, Innovation and Employment (UOAX0815 Doctoral Scholarship, UOAX0815, UOAX0815)
- University of Auckland (Doctoral Scholarship and PReSS account)
- Maurice and Phyllis Paykel Trust (Verious project and equipment grants, Various equipment grants)
- Lottery Health Research (Various equipment grants)
This publication has 64 references indexed in Scilit:
- IAPP in type II diabetes: Basic research on structure, molecular interactions, and disease mechanisms suggests potential intervention strategiesBiochimica et Biophysica Acta (BBA) - Biomembranes, 2018
- IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040Diabetes Research and Clinical Practice, 2017
- Hyperinsulinemia Drives Diet-Induced Obesity Independently of Brain Insulin ProductionCell Metabolism, 2012
- Selective Insulin and Leptin Resistance in Metabolic DisordersCell Metabolism, 2012
- Diabetes Mellitus and the β Cell: The Last Ten YearsCell, 2012
- Brain Insulin Controls Adipose Tissue Lipolysis and LipogenesisCell Metabolism, 2011
- Identification of central projections from amylin-activated neurons to the lateral hypothalamusBrain Research, 2010
- Reversible Ponceau staining as a loading control alternative to actin in Western blotsAnalytical Biochemistry, 2010
- Is type 2 diabetes an amyloidosis and does it really matter (to patients)?Diabetologia, 2010
- Lesion of the lateral parabrachial nucleus attenuates the anorectic effect of peripheral amylin and CCKBrain Research, 2007